Skip to main content
COSMO BIO COMPANY, LIMITED logo

COSMO BIO COMPANY, LIMITED — Investor Relations & Filings

Ticker · 3386 ISIN · JP3298700000 T Wholesale and retail trade
Open in API
Filings indexed 82 across all filing types
Latest filing 2026-05-21 Transaction in Own Shar…
Country JP Japan
Listing T 3386

About COSMO BIO COMPANY, LIMITED

https://www.cosmobio.com/

COSMO BIO COMPANY, LIMITED is a supplier and manufacturer of products for the life science research community. The company's core business involves providing a comprehensive portfolio of research reagents, instruments, and related services to laboratories, research institutes, and educational organizations. It offers both its own manufactured products and serves as a distributor for a global network of trusted manufacturers. This dual role allows the company to supply an extensive range of high-quality, up-to-date products and technical information, supporting researchers in advancing biomedical and life science studies.

Recent filings

Filing Released Lang Actions
従業員に対する譲渡制限付株式としての自己株式処分の払込完了に関するお知らせ
Transaction in Own Shares Classification · 87% confidence The document is a Japanese disclosure titled “従業員に対する譲渡制限付株式としての自己株式処分の払込完了に関するお知らせ,” which announces the completion of payment for the disposal of treasury shares (自己株式処分) to employees under a restricted share plan. This is not a regular financial report but a corporate action involving the company’s own shares. Under FinancialReports categories, announcements of share repurchases or disposals of treasury stock fall under “Transaction in Own Shares” (Code: POS).
2026-05-21 Japanese
2026年12月期 第１四半期決算短信〔日本基準〕（連結）
Regulatory Filings
2026-05-08 Japanese
取締役に対する譲渡制限付株式としての自己株式処分の払込完了に関するお知らせ
Regulatory Filings
2026-04-21 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2025
2026-03-18 Japanese
有価証券報告書－第43期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, management indicators, and is filed under the Financial Instruments and Exchange Act. The document structure, including the cover page and the 'Part 1: Corporate Information' section, confirms it is the full annual financial report for the fiscal year ending December 31, 2025. FY 2025
2026-03-18 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a '自己株券買付状況報告書' (Report on Status of Purchase of Own Shares) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. This document details the company's share buyback activity for the period of July 2025, including daily transaction data and cumulative totals. According to the provided definitions, reports regarding a company buying back its own shares are classified as 'Transaction in Own Shares' (POS).
2025-08-12 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.